skip to Main Content

Penn Researchers Help Unravel Mysteries of Pancreatic Cancer’s Resistance to Standard Therapies

Penn Researchers Help Unravel Mysteries of Pancreatic Cancer’s Resistance to Standard Therapies

Pancreatic cancer has long been one of the hardest to treat.

Now, in a new study, researchers at the Perelman School of Medicine at the University of Pennsylvania have illuminated one of this cancer’s major resistance mechanisms: a form of inflammation that is triggered by the tumor in response to treatment and helps keep tumor cells alive.

Blocking this inflammation after radiation therapy brought a significant improvement in survival in a mouse model of the disease. Read more . . .


Back To Top